RTOG-0815
Terminated
Protocol Information
Tab containing protocol details, study design, and eligibility criteria
Tab containing study documents, informed consent forms, and study materials
Tab containing information for potential study participants
A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without Short-Term Androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer
Principal Investigator
Alvaro A. Martinez
Status
Terminated
Open to Accrual
September 14, 2009
Closed to Accrual
March 7, 2016
Closed to Accrual & Treatment
June 2, 2016
Complete
April 27, 2023
Terminated
September 4, 2025
Disease Site
Genitourinary [GU] Prostate
Phase
III
Developmental Therapeutics
No
Primary Objective
Data Collection Notice:
Data for this trial is being collected via the NRG/RTOG Data Center.
Patient Population
–
Target Accrual
1520
Protocol Documents
Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.
-
Share this study.
-
-
-
-
